BioMarin to buy Prosensa in $840 mln deal
November 24, 2014 at 06:24 AM EST
Nov 24 (Reuters) - BioMarin Pharmaceuticals Inc said it would buy Dutch drug developer Prosensa Holding NV for about $840 million including milestone payments, aiming to add to its portfolio of drugs to treat rare diseases.